AN1
Click for more information
0.00% 0.8¢ anagenics limited

Ann: EGM Presentation by CEO, page-4

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
  1. Squawk_Box
    16 Posts.
    lightbulb Created with Sketch. 1
    clock Created with Sketch.
    09/09/18
    07:33
    Post #: 35480817

    Good morning, did any one attend the EGM?


    Interested to know the following:


    1. How many directors were in attendance?

    2. How many shareholders attended (any major or long term holders)?

    3. How did Dennis Eck come across?

    4. How was the relationship between the Chairman and the new #1 holder and director Dennis Eck?

    5. Did Dennis give any insights into the beauty and anti ageing industry in America & thoughts on Cellmid?

    6. Any news on Cellmids expanding footprint into China?

    7. Any comments made on spinning off or an IPO for Advangen?

    8. Further market expansions?

    9. Any news on Fillerina?

    10. Crown Jewels, Midkine?

    11. Anything else, market capitalisation or share price targets?


    CDY Price at posting: 39.5¢ Sentiment: None Disclosure: Held
    Likes Created with Sketch. 2  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Canyon-1H well drilling advancing as planned, with promising results observed and key milestones on track for completion by late October
right-arrow Created with Sketch.
NVU Nanoveu To Acquire Leading SoC Semiconductor Company
right-arrow Created with Sketch.
NEWS MOU executed with leading maritime partner to advance plans for a multi-user transhipping facility in West Pilbara
right-arrow Created with Sketch.
LGP Record revenue of $10.2 million as European demand drives 40% quarterly growth, with $1 million in operating cash inflow and $0.5 million in cost savings forecast
right-arrow Created with Sketch.
NEWS First-ever treatment for Rett syndrome approved in Canada, opening new possibilities for patients and boosting potential royalty payments—discover more about DAYBUE™'s breakthrough
right-arrow Created with Sketch.
NEWS The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint
right-arrow Created with Sketch.
watchlist Created with Sketch. Add AN1 (ASX) to my watchlist
(20min delay)
Last
0.8¢ 		Change
0.000(0.00%) 		Mkt cap ! $3.690M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0
AN1 (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.